Insulated cold-pack shipping · Lot-traceable · Published certificates
Research use only
Research-use disclosure
NextGen products are sold strictly for laboratory research. By entering this catalog you confirm you are at least 21 years old and you agree to our terms, privacy policy, and the use of cookies.
Insulated cold-pack shipping · Lot-traceable · Published certificates
Research use only
Lot Reference
NXG-LOT-—
Laboratory reference material
In stock · ships from the US
ARA-290 (cibinetide) is an 11-amino-acid peptide derived from the helix-B domain of erythropoietin, engineered to engage the innate repair receptor — a heteromeric complex of the erythropoietin receptor and the β-common receptor — without stimulating erythropoiesis. In-vitro and preclinical research literature characterizes receptor engagement modulating inflammatory and tissue-protective signaling pathways independent of the classical EPO/hematopoietic axis.
Specification sheet
Certificate of analysis
Not published for this compound yet.Request the certificate for your lot →
Use
Research use only · non-human
Return policy
All sales final · defective-lot replacement only
Analytical-grade biochemical reference material supplied strictly for in-vitro laboratory research and development. Not a drug, food, dietary supplement, cosmetic, or medical device; not approved by the U.S. Food and Drug Administration; not for human or animal consumption, or for therapeutic, clinical, or diagnostic use, dosing, injection, ingestion, or administration of any kind. Sold only to qualified researchers aged 21 or older.